CD20: Difference between revisions
From haematologyetc.co.uk
(Created page with "<div style="background-color: #E0EEEE; {{round corners}} padding: 2em 2em; margin-right: 5px;"> :<span style="color:navy">'''Summary'''</span> :CD20 is a component of the B-cell receptor and is therefore expressed by mature B-lymphocytes. In many ways its expression is similar to that of CD19; however CD20 expression is acquired slightly later in B cell development and may be retained by somr plasma cells. </div> :<span style="color:navy">'''Background'''</span>...") |
No edit summary |
||
Line 4: | Line 4: | ||
:<span style="color:navy">'''Summary'''</span> | :<span style="color:navy">'''Summary'''</span> | ||
:CD20 is a component of the B-cell receptor and is therefore expressed by mature B-lymphocytes. In many ways its expression is similar to that of CD19; however CD20 expression is acquired slightly later in B cell development and may be retained by | :CD20 is a component of the B-cell receptor and is therefore expressed by mature B-lymphocytes. In many ways its expression is similar to that of CD19; however CD20 expression is acquired slightly later in B cell development and may be retained by some plasma cells. | ||
Latest revision as of 13:58, 6 July 2023
- Summary
- CD20 is a component of the B-cell receptor and is therefore expressed by mature B-lymphocytes. In many ways its expression is similar to that of CD19; however CD20 expression is acquired slightly later in B cell development and may be retained by some plasma cells.
- Background
CD20 is expressed by B-cells at late developmental stages including expression by some plasma cells.
- Diagnostic Use
- CD20 is regarded as a pan-B-cell marker and may be useful in the diagnosis of mature B-cell types if other patterns are atypical
- Low levels of CD20 expression may be helpful in the recognition of CLL (similar to CD19, CD79b and light-chains)
- CD20 is the target of rituximab and other therapeutic antibodies so expression may be absent from neoplastic cells relapsing after treatment with these antibodies